Company Name: Dynavax Technologies Corporation

Dynavax Technologies Corporation is a clinical stage biopharmaceutical company. The company is engaged in the development of therapeutics and vaccines using toll-like receptor biology. The company’s areas of focus include infectious diseases and cancer immunotherapy as well as autoimmune and inflammatory diseases. The company’s lead product candidates include a hepatitis B vaccine and a cancer immunotherapy.

Ticker Symbol: DVAX (NASDAQ)

Company Website:

Social Media: Dynavax Technologies LinkedIn

Headquarters: Berkeley, CA